THE INVESTIGATION OF BYSTANDER EFFECT AFTER BLEOMYCIN ELECTROTRANSFER OR IRREVERSIBLE ELECTROPORATION IN BETWEEN CELL LINES

Ugnė Borinskytė1, Neringa Barauskaitė1, Paulius Ruzgys1, Vitalij Novickij2, Saulius Šatkauskas1

1 Biophysical Research Group, Faculty of Natural Sciences, Vytautas Magnus University, Lithuania

2 Institute of High Magnetic Fields, Vilnius Gediminas Technical University, Naugarduko st. 4103227, LT-10224 Vilnius, Lithuania

Cancer is a major public health problem worldwide and the second leading cause of death in the United States [1]. Therefore, currently cancer treatment research is a leading topic worldwide. Hence alternative anticancer treatments are being applied as a substitute to conventional ones. One of most promising novel anticancer therapies are electrochemotherapy and electroablation [2]. Both methods are based on the phenomenon of electroporation, that is dependent on the formation of the electropores in the affected cell membranes. Such process occurs as a result of electric field triggered transmembrane potential increase [3]. Pore formation is initiated when transmembrane potential surpasses the electroporation threshold. Reversible electroporation is triggered if transmembrane potential does not deviate far from the electroporation threshold. In other case of scenario transmembrane potential greatly exceed the electroporation threshold, hence irreversible electroporation is induced.

The phenomenon of reversible electroporation is used in clinics as a cellular membrane permeabilization method for various hydrophilic molecules, such as anticancer drug bleomycin, to be transferred into the malignant cell cytosol. Such combination of both treatments is termed as electrochemotherapy. Similarly, irreversible electroporation induces another anticancer treatment termed as electroablation.

Both of the mentioned methods are local, thus are comparable to radiotherapy, as it is also a local conventional cancer treatment method. It is known that cell affected by ionizing radiation can trigger the bystander effect on the adjacent cells. Recently, few publications had shown that the bystander effect is present after both electroporation driven cancer treatment methods, namely electrochemotherapy and electroablation [4]. However, there is still a lack of research that could respectively describe the phenomenon of bystander effect after both electroporation triggered cancer treatment methods. Moreover, none of the studies to date evaluate the bystander effect dependance on cell lines. Even more, it is still not known whether the bystander effect could be initiated in between the different cell lines.

The bystander effect triggered by irreversible electroporation or bleomycin electrotransfer was carried out in vitro. Chinese hamster ovary cells (CHO-K1) and human adenocarcinoma alveolar basal epithelial cell (A549) lines are used for experiments. The electrotransfer of the anticancer drug BLM (20 nM) was performed with one electrical pulse at (1400 V/cm) for the duration of 100 μs. Irreversible electroporation was performed also with a single electrical pulse at (2800 V/cm) for the duration of 100 μs. After electroporation, cells were incubated for 10 min, then 1 ml of RPMI growth media was applied on top and incubated for 72 hours in a 6-well plate. After incubation, the medium is collected and centrifuged twice. Then the collected media was applied on 400 cells in the 4 cm petri dish. Cell colony formation assay was performed form those cells.

The results presented here indicate that the bystander effect triggered by bleomycin electrotransfer is significantly decreasing CHO and A-549 cell viability. Furthermore, the bystander effect has similar effect on different cell lines i.e., bleomycin electrotransfer was performed on CHO cells and the media was transferred on A-549 cells or vice versa. However irreversible electroporation did not trigger positive bystander effect as with CHO cell lines.


[1] R. L. Siegel, K. D. Miller and Jemal, A., Cancer statistics, 2020. CA: A Cancer Journal for Clinicians. 70, 7-30, 2020.

[2] Y. Peng, H. Tao, Y. Gao, Y. Yang and Chen, Z., Review and Prospect of Tissue-agnostic Targeted Strategies in Anticancer Therapies, Curr. Top. Med. Chem., 21, 404-425, 2020.

[3] B. Geboers, H. J. Scheffer, P. M. Graybill, A. H. Ruarus, S. Nieuwenhuizen, R. S. Puijk, P. M. van den Tol, R. V. Davalos, B. Rubinsky, T. D. De Gruijl, D. Miklavčič and Meijerink, M. R., High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy. Radiology. 295, 254-272, 2020.

[4] P. Ruzgys, N. Barauskaitė, V. Novickij, J. Novickij and Šatkauskas, S., The Evidence of the Bystander Effect after Bleomycin Electrotransfer and Irreversible Electroporation. Molecules. 26, 6001, 2021.